The most common treatment to lower IOP—the only treatable risk factor in glaucoma—is
with medicated eyedrops, like LUMIGAN® ophthalmic solution.
LUMIGAN® therapy is thought to lower IOP by enhancing the outflow
of aqueous humor, helping it to drain through 2 separate
pathways out of the eye. This dual method of outflow makes LUMIGAN®
an effective therapy to lower IOP and help manage glaucoma. To watch a video explaining
the outflow process, click here.
Although glaucoma cannot be cured, National Eye Institute clinical
studies have shown that lowering IOP can reduce the risk for vision loss.
LUMIGAN® 0.01% and 0.03% (bimatoprost ophthalmic solution) is used
for the treatment of high eye pressure, also called intraocular pressure (IOP),
in people with open-angle glaucoma or ocular hypertension.
Important Safety Information
LUMIGAN® 0.01% and 0.03% (bimatoprost ophthalmic solution) has been
reported to cause darkening (pigmentation) of eye color, eyelid skin, and eyelashes
as well as increased growth of eyelashes. Pigmentation changes can increase as long
as LUMIGAN® 0.01% and 0.03% is used. After stopping LUMIGAN®
0.01% and 0.03%, darkening of eye color is likely to be permanent, while darkening
of the eyelid skin and eyelash changes may be reversible. The effects of increased
darkening beyond 5 years are not known.
When only one eye is treated, there is a possibility of eyelash changes in the eye
treated with LUMIGAN® 0.01% and 0.03%. These changes may result in
differences between the eyes in eyelash length, thickness, darkness, number of eyelashes,
and/or direction of eyelash growth. These changes are usually reversible upon stopping
LUMIGAN® 0.01% and 0.03% therapy.
Avoid allowing the tip of the dispensing bottle to touch the eye, anything around
the eye, fingers, or any other surface in order to avoid contamination by common
bacteria known to cause eye infections. Serious damage to the eye and loss of vision
may result from using contaminated solutions.
If you have eye surgery or develop any eye reactions (such as trauma or infection),
immediately consult with your physician about continuing the use of LUMIGAN®
0.01% and 0.03%.
If you wear contact lenses, remove them before using LUMIGAN® 0.01%
and 0.03%. Then wait 15 minutes after using LUMIGAN® 0.01% and 0.03%
before you put your contacts back into your eyes.
The most common side effects are eye redness, growth of eyelashes, and itchy eyes.
Click here
for full prescribing information.